Department of Biology and Biological Engineering, Division of Systems and Synthetic Biology, Chalmers University of Technology, Gothenburg, Sweden.
Discovery Sciences, Biopharmaceutical R&D, AstraZeneca, Cambridge, UK.
SLAS Discov. 2021 Jun;26(5):581-603. doi: 10.1177/24725552211000669. Epub 2021 Apr 9.
The global impact of synthetic biology has been accelerating, because of the plummeting cost of DNA synthesis, advances in genetic engineering, growing understanding of genome organization, and explosion in data science. However, much of the discipline's application in the pharmaceutical industry remains enigmatic. In this review, we highlight recent examples of the impact of synthetic biology on target validation, assay development, hit finding, lead optimization, and chemical synthesis, through to the development of cellular therapeutics. We also highlight the availability of tools and technologies driving the discipline. Synthetic biology is certainly impacting all stages of drug discovery and development, and the recognition of the discipline's contribution can further enhance the opportunities for the drug discovery and development value chain.
由于 DNA 合成成本的大幅降低、基因工程的进步、对基因组组织的理解不断加深以及数据科学的爆炸式发展,合成生物学的全球影响力一直在加速。然而,该学科在制药行业的应用在很大程度上仍然是个谜。在这篇综述中,我们通过强调合成生物学对靶标验证、检测方法开发、命中发现、先导化合物优化和化学合成,直至细胞治疗的发展的影响的最新例子来突出这一点。我们还强调了推动这一学科的工具和技术的可用性。合成生物学肯定正在影响药物发现和开发的所有阶段,对该学科贡献的认识可以进一步增强药物发现和开发价值链的机会。